Gefitinib for EGFR mutated lung adenocarcinoma during pregnancy: A case report with 5-Year Follow-Up.

doi:10.1016/j.lungcan.2025.108456

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Gefitinib for EGFR mutated lung adenocarcinoma during pregnancy: A case report with 5-Year Follow-Up.

Lung cancer (Amsterdam, Netherlands) - 1 Apr 2025

Messekher Merouane, Fuchs Florent, Badr Maliha, Pujol Jean-Louis

Abstract excerpt

We report the case of a 37-year-old pregnant woman at 19 weeks of gestation who was diagnosed with a stage M1b EFGRmut lung adenocarcinoma, in 2019. After a right upper and middle bilobectomy (T3N1 and R0 pathological status) and a complete cerebellar metastasis resection, she was treated with gefitinib, which offered her a prolonged recurrence-free survival without any negative consequence for the fetal...

Read the complete abstract on PubMed

Topics

Humans
Female
Gefitinib
Pregnancy
Adenocarcinoma of Lung
Lung Neoplasms
Adult

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

ErbB Receptors

Mutation

Pregnancy Complications, Neoplastic

Follow-Up Studies

Antineoplastic Agents

Protein Kinase Inhibitors

Treatment Outcome

Source

Open in PubMed

Identifiers

PMID: 40117847
DOI: 10.1016/j.lungcan.2025.108456

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Gefitinib for EGFR mutated lung adenocarcinoma during pregnancy: A case report with 5-Year Follow-Up.PMID 40117847Read ↗

Use of erlotinib throughout pregnancy: a case-report of a patient with metastatic lung adenocarcinoma.Semantic proximity Read ↗

Efficacy and safety of gefitinib during pregnancy: case report and literature review.Semantic proximity Read ↗

Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma.Semantic proximity Read ↗

Lung cancer and pregnancy.Semantic proximity Read ↗

Unexpected elevation of β-hCG in EGFR-mutant lung adenocarcinoma: a case study and implications for clinical practice.Semantic proximity Read ↗

Successful Treatment of Non-Small Cell Lung Cancer With Erlotinib Throughout Pregnancy.Semantic proximity Read ↗

Genotype-directed therapy for non-small cell lung cancer diagnosed during pregnancy: A pooled analysis of seven cases from the Cancer and Pregnancy Registry with maternal and neonatal outcomes and review of the literature.Semantic proximity Read ↗

Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.